<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
Vera Therapeutics stock jumps after the FDA approved its autoimmune kidney drug

Trutakna, priced at $425,000 per year, is the first drug approved in the U.S. that targets both BAFF and APRIL proteins linked to IgA nephropathy [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
The FDA approves human trials for pig kidney transplants

Despite how it sounds, a xenotransplant isn't something from the latest Alien movie. It's an increasingly credible science: the transplantation of animal organs into humans. The field took o [...]

Match Score: 181.65

venturebeat
Nvidia introduces Vera Rubin, a seven-chip AI platform with OpenAI, Anthropic and Meta on board

Nvidia on Monday took the wraps off Vera Rubin, a sweeping new computing platform built from seven chips now in full production — and backed by an extraordinary lineup of customers that includes Ant [...]

Match Score: 161.99

thenextweb
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]

Match Score: 72.18

venturebeat
Nvidia’s Vera Rubin is months away — Blackwell is getting faster right now

The big news this week from Nvidia, splashed in headlines across all forms of media, was the company's announcement about its Vera Rubin GPU.This week, Nvidia CEO Jensen Huang used his CES keynot [...]

Match Score: 71.16

Destination
The FDA rolls out its own AI to speed up clinical reviews and scientific evaluations

The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinforma [...]

Match Score: 67.78

qz
UCB is snapping up U.S. autoimmune biotech Candid Therapeutics for $2.2 billion

The Belgian pharma company is paying $2 billion upfront for Candid's pipeline of T-cell engagers targeting autoimmune diseases [...]

Match Score: 63.35

Destination
8 key drug patents expiring soon — and what it means for the market

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s wholesale price drops by an average of 39% after just one generic competitor en [...]

Match Score: 53.10

Destination
FDA employees say the agency's Elsa generative AI hallucinates entire studies

Current and former members of the FDA told CNN about issues with the Elsa generative AI tool unveiled by the federal agency last month. Three employees said that in practice, Elsa has hallucinated non [...]

Match Score: 52.54

Destination
The Vera C. Rubin Observatory shares first images from planned decade-long survey of the sky

The National Science Foundation just shared the first images captured by the Vera C. Rubin Observatory, a sample of the footage it'll capture as part of a planned decade-long survey that's s [...]

Match Score: 50.16